Metraipolis › archive › dc_10b323264683

Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey — Europe PMC PMID:41052287

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41052287
DOI
10.1093/oncolo/oyaf333
License (as archived)
solo-consultazione
Archived
2026-10-08T08:47:17.977Z
SHA-256 of the archived text
4a686de9e9a3eb8cd7f706362cdaf393aee9da44eeaf32ce66534c217e5e3978
Stable URL of this page
https://metraipolis.com/documento/dc_10b323264683

How to cite

Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey — Europe PMC PMID:41052287 — Europe PMC (en), https://europepmc.org/article/MED/41052287 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_10b323264683 (Metraipolis archive dc_10b323264683, sha256 4a686de9e9a3eb8cd7f706362cdaf393aee9da44eeaf32ce66534c217e5e3978)
BibTeX
@misc{dc10b323264683,
  title = {Guiding first-line treatment decisions in advanced urothelial carcinoma: a global survey — Europe PMC PMID:41052287},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41052287},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_10b323264683; sha256 4a686de9e9a3eb8cd7f706362cdaf393aee9da44eeaf32ce66534c217e5e3978},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41052287. Agents can read the archived copy with the MCP tool read_document.